1 |
Hamilton BE, Hoyert DL, Martin JA, et al. Annual summary of vital statistics: 2010-2011 [J]. Pediatrics, 2013, 131(3): 548-558.
|
2 |
Gregory KD, Jackson S, Korst L, et al. Cesarean versus vaginal delivery: whose risks? Whose benefits? [J]. Am J Perinatol, 2012, 29(1): 7-18.
|
3 |
American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine. Obstetric care consensus No. 1: safe prevention of the primary cesarean delivery [J]. Obstet Gynecol, 2014, 123(3): 693-711.
|
4 |
Guise JM, Eden K, Emeis C, et al. Vaginal birth after cesarean: new insights [J]. Evid Rep Technol Assess (Full Rep), 2010, 191: 1-397.
|
5 |
Clark SL, Belfort MA, Dildy GA, et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery [J]. Am J Obstet Gynecol, 2008, 199(1): 36.e1-e5; discussion 91-92. e7-e11.
|
6 |
Barber EL, Lundsberg LS, Belanger K, et al. Indications contributing to the increasing cesarean delivery rate [J]. Obstet Gynecol, 2011, 118(1): 29-38.
|
7 |
Friedman EA, Sachtleben MR. Amniotomy and the course of labor [J]. Obstet Gynecol,1963, 22: 755-770.
|
8 |
Friedman E. The graphic analysis of labor [J]. Am J Obstet Gynecol, 1954, 68(6): 1568-1575.
|
9 |
Zhang J, Landy HJ, Branch DW, et al. Contemporary patterns of spontaneous labor with normal neonatal outcomes [J]. Obstet Gynecol, 2010, 116(6): 1281-1287.
|
10 |
Arulkumaran S, Koh CH, Ingemarsson I, et al. Augmentation of labour: mode of delivery related to cervimetric progress [J]. Aust N Z J Obstet Gynaecol, 1987, 27(4): 304-308.
|
11 |
Rouse DJ, Owen J, Hauth JC. Active-phase labor arrest: oxytocin augmentation for at least 4 hours [J]. Obstet Gynecol, 1999, 93(3): 323-328.
|
12 |
Rouse DJ, Owen J, Savage KG, et al. Active phase labor arrest: revisiting the 2-hour minimum [J]. Obstet Gynecol, 2001, 98(4): 550-554.
|
13 |
Henry DE, Cheng YW, Shaffer BL, et al. Perinatal outcomes in the setting of active phase arrest of labor [J]. Obstet Gynecol, 2008, 112(5): 1109-1115.
|
14 |
Piper JM, Bolling DR, Newton ER. The second stage of labor: factors influencing duration [J]. Am J Obstet Gynecol, 1991, 165(4 Pt 1): 976-979.
|
15 |
Rouse DJ, Weiner SJ, Bloom SL, et al. Second-stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes [J]. Am J Obstet Gynecol, 2009, 201(4): 357.e1-e7.
|
16 |
Le Ray C, Audibert F, Goffinet F, et al. When to stop pushing: effects of duration of second-stage expulsion efforts on maternal and neonatal outcomes in nulliparous women with epidural analgesia [J]. Am J Obstet Gynecol, 2009, 201(4): 361. e1-e7.
|
17 |
Cheng YW, Hopkins LM, Caughey AB. How long is too long: does a prolonged second stage of labor in nulliparous women affect maternal and neonatal outcomes? [J]. Am J Obstet Gynecol, 2004, 191(3): 933-938.
|
18 |
Cheng YW, Hopkins LM, Laros RK Jr, et al. Duration of the second stage of labor in multiparous women: maternal and neonatal outcomes [J]. Am J Obstet Gynecol, 2007, 196(6): 585. e1-e6.
|
19 |
Allen VM, Baskett TF, O'Connell CM, et al. Maternal and perinatal outcomes with increasing duration of the second stage of labor [J]. Obstet Gynecol, 2009, 113(6): 1248-1258.
|
20 |
Cheng YW, Shaffer BL, Bianco K, et al. Timing of operative vaginal delivery and associated perinatal outcomes in nulliparous women [J]. J Matern Fetal Neonatal Med, 2011, 24(5): 692-697.
|
21 |
Spong CY, Berghella V, Wenstrom KD, et al. Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists workshop. In reply [J]. Obstet Gynecol, 2013, 121(3): 687.
|
22 |
Srinivas SK, Epstein AJ, Nicholson S, et al. Improvements in US maternal obstetrical outcomes from 1992 to 2006 [J]. Med Care, 2010, 48(5): 487-493.
|
23 |
Towner D, Castro MA, Eby-Wilkens E, et al. Effect of mode of delivery in nulliparous women on neonatal intracranial injury [J]. N Engl J Med, 1999, 341(23): 1709-1714.
|
24 |
Werner EF, Janevic TM, Illuzzi J, et al. Mode of delivery in nulliparous women and neonatal intracranial injury [J]. Obstet Gynecol, 2011, 118(6): 1239-1246.
|
25 |
O'Mahony F, Hofmeyr GJ, Menon V. Choice of instruments for assisted vaginal delivery [J]. Cochrane Database Syst Rev, 2010,11: CD005455.
|
26 |
Powell J, Gilo N, Foote M, et al. Vacuum and forceps training in residency: experience and self-reported competency [J]. J Perinatol, 2007, 27(6): 343-346.
|
27 |
Shaffer BL, Caughey AB. Forceps delivery: potential benefits and a call for continued training [J]. J Perinatol, 2007, 27(6): 327-328.
|
28 |
Cheng YW, Hubbard A, Caughey AB, et al.The association between persistent fetal occiput posterior position and perinatal outcomes: an example of propensity score and covariate distance matching [J]. Am J Epidemiol, 2010, 171(6): 656-663.
|
29 |
Shaffer BL, Cheng YW, Vargas JE, et al. Manual rotation to reduce caesarean delivery in persistent occiput posterior or transverse position [J]. J Matern Fetal Neonatal Med, 2011, 24(1): 65-72.
|
30 |
Reichman O, Gdansky E, Latinsky B, et al. Digital rotation from occipito-posterior to occipito-anterior decreases the need for cesarean section [J]. Eur J Obstet Gynecol Reprod Biol, 2008, 136(1): 25-28.
|
31 |
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 106: intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles [J]. Obstet Gynecol, 2009, 114(1): 192-202.
|
32 |
American College of Obstetricians and Gynecologists. Practice bulletin No. 116: management of intrapartum fetal heart rate tracings [J]. Obstet Gynecol, 2010, 116(5): 1232-1240.
|
33 |
Clark SL, Gimovsky ML, Miller FC. The scalp stimulation test: a clinical alternative to fetal scalp blood sampling [J]. Am J Obstet Gynecol, 1984, 148(3): 274-277.
|
34 |
Cahill AG, Roehl KA, Odibo AO, et al. Association and prediction of neonatal acidemia [J]. Am J Obstet Gynecol, 2012, 207(3): 206. e1-e8.
|
35 |
Elimian A, Figueroa R, Tejani N. Intrapartum assessment of fetal well-being: a comparison of scalp stimulation with scalp blood pH sampling [J]. Obstet Gynecol, 1997, 89(3): 373-376.
|
36 |
MacGregor SN, Banzhaf WC, Silver RK, et al. A prospective, randomized evaluation of intrapartum amnioinfusion. Fetal acid-base status and cesarean delivery [J]. J Reprod Med, 1991, 36(1): 69-73.
|
37 |
Macri CJ, Schrimmer DB, Leung A, et al. Prophylactic amnioinfusion improves outcome of pregnancy complicated by thick meconium and oligohydramnios [J]. Am J Obstet Gynecol, 1992, 167(1): 117-121.
|
38 |
Pearlman MD, Klinich KD, Schneider LW, et al. A comprehensive program to improve safety for pregnant women and fetuses in motor vehicle crashes: a preliminary report [J]. Am J Obstet Gynecol,2000, 182(6): 1554-1564.
|
39 |
Stewart RD, Bleich AT, Lo JY, et al. Defining uterine tachysystole: how much is too much? [J]. Am J Obstet Gynecol, 2012, 207(4): 290. e1-e6.
|
40 |
Garite TJ, Simpson KR. Intrauterine resuscitation during labor [J]. Clin Obstet Gynecol, 2011, 54(1): 28-39.
|
41 |
Lee HC, El-Sayed YY, Gould JB. Population trends in cesarean delivery for breech presentation in the United States, 1997-2003 [J]. Am J Obstet Gynecol, 2008, 199(1): 59.e1-e8.
|
42 |
Clock C, Kurtzman J, White J, et al. Cesarean risk after successful external cephalic version: a matched, retrospective analysis [J]. J Perinatol, 2009, 29(2): 96-100.
|
43 |
Yoshida M, Matsuda H, Kawakami Y, et al. Effectiveness of epidural anesthesia for external cephalic version (ECV) [J]. J Perinatol, 2010, 30(9): 580-583.
|
44 |
Little SE, Edlow AG, Thomas AM, et al. Estimated fetal weight by ultrasound: a modifiable risk factor for cesarean delivery? [J]. Am J Obstet Gynecol, 2012, 207(4): 309. e1-e6.
|
45 |
Durie DE, Thornburg LL, Glantz JC. Effect of second-trimester and third-trimester rate of gestational weight gain on maternal and neonatal outcomes [J]. Obstet Gynecol, 2011, 118(3): 569-575.
|
46 |
Lee HC, Gould JB, Boscardin WJ, et al. Trends in cesarean delivery for twin births in the United States: 1995-2008 [J]. Obstet Gynecol, 2011, 118(5): 1095-1101.
|
47 |
Barrett JF, Hannah ME, Hutton EK, et al. A randomized trial of planned cesarean or vaginal delivery for twin pregnancy [J]. N Engl J Med, 2013, 369(14): 1295-1305.
|
48 |
Sheffield JS, Hill JB, Hollier LM, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial [J]. Obstet Gynecol, 2006, 108(1): 141-147.
|
49 |
Little SE, Caughey AB. Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis [J]. Am J Obstet Gynecol, 2005, 193(3 Pt 2): 1274-1279.
|
50 |
ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy [J]. Obstet Gynecol, 2007, 109(6): 1489-1498.
|
51 |
Hodnett ED, Gates S, Hofmeyr GJ, et al. Continuous support for women during childbirth [J]. Cochrane Database Syst Rev, 2013, 7: CD003766.
|